Gene and pathway enrichment analyses of G-set-1/2 identified several Erk1/2i + CDK4/6i targets that are implicated in MM parthenogenesis (FGFR3, BCMA, IRF4, and GABARAP) (Fig. 8D1, 2). The gene discussed is CDK4; the disease is Miyoshi myopathy.